CUROVERSE, INC.
AcquiredBoston, US · Founded 2010 · 2 known investors
Find your way into CUROVERSE, INC.
Sign up to see every warm intro you have to CUROVERSE, INC.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the CUROVERSE, INC. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Acquired by Veritas Genetics August 2017 · terms undisclosed — Undisclosed · source ↗
Curoverse provides solutions built on Arvados, an open source computing platform for managing and processing large-scale data from terabytes to petabytes. The platform combines content-addressable storage with a containerized workflow engine and runs on major cloud providers and on premise.
Founders & leadership
CUROVERSE, INC. was founded in 2010 by Ward Vandewege, Alexander Wait Zaranek, and Adam Berrey.
Board
Investors · 2
Reported raises · per SEC filings
Form D private placements$2.2M disclosed across 2 rounds · 2013–2015
▶$500KraisedMar 2015 · 3 investors · OtherRule 506(b)
- Alexander Wait ZaranekDirector
- David MartiranoDirector
- Jeremy AllaireDirector
- Adam BerreyExecutive Officer, Director
- Clay ThropDirector
- Ward VandewegeExecutive Officer
- Offering amount
- $2M
- Amount sold
- $500K
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
▶$1.7MraisedFeb 2014 · 15 investors · OtherRule 506(b)
- Michael DialDirector
- Ward VandewegeExecutive Officer
- David MartiranoDirector
- Alexander Wait ZaranekDirector
- Adam BerreyExecutive Officer, Director
- Offering amount
- $1.7M
- Amount sold
- $1.7M
- First sale
- Aug 2013
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2014 | $299.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does CUROVERSE, INC. do?
- Curoverse provides solutions built on Arvados, an open source computing platform for managing and processing large-scale data from terabytes to petabytes. The platform combines content-addressable storage with a containerized workflow engine and runs on major cloud providers and on premise.
- Who founded CUROVERSE, INC.?
- CUROVERSE, INC. was founded by Ward Vandewege, Alexander Wait Zaranek, Adam Berrey in 2010.
- Who are CUROVERSE, INC.'s investors?
- CUROVERSE, INC.'s investors include Hatteras Venture Partners, Hyperplane Venture Capital.
- How much funding has CUROVERSE, INC. raised?
- CUROVERSE, INC. has disclosed $2.2M raised across 2 rounds.
- Where is CUROVERSE, INC. headquartered?
- CUROVERSE, INC. is headquartered in Boston, US.
